Citation Impact
Citing Papers
Systematic review: human gut dysbiosis induced by non‐antibiotic prescription medications
2017
Proton pump inhibitors alter the composition of the gut microbiota
2015
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Molecular and structural aspects of fimbriae biosynthesis and assembly inEscherichia coli
1996
Extended Virulence Genotypes ofEscherichia coliStrains from Patients with Urosepsis in Relation to Phylogeny and Host Compromise
2000 Standout
Classification and Grading of Gastritis
1996 Standout
Bacterial Biofilms in Nature and Disease
1987 Standout
Effects of Acid Suppression and Bismuth Medications on The Performance of Diagnostic Tests for Helicobacter Pylori Infection
1999
Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta‐analysis
2002
Bacterial Killing by Neutrophils in Hypertonic Environments
1994
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Device‐Associated Infections: A Macroproblem that Starts with Microadherence
2001 Standout
Diversity of the Escherichia coli Type 1 Fimbrial Lectin
1997
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics
2020 Standout
Antibacterial properties of nanoparticles
2012 Standout
Effect of Proton-Pump Inhibitor Therapy on Diagnostic Testing for Helicobacter pylori
1998
State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men
1998 Standout
Tamm-Horsfall Protein Binds to Type 1 Fimbriated Escherichia coli and Prevents E. coli from Binding to Uroplakin Ia and Ib Receptors
2001
Bacterial Adhesion: Genetics, Biogenesis, and Role in Pathogenesis of Fimbrial Adhesins of Escherichia coli
1991
Hp and pH: Implications for the Eradication of Helicobacter pylori
1993
Adhesins as Lectins: Specificity and Role in Infection
1990
Biological roles of glycans
2016 Standout
Neutrophils and immunity: challenges and opportunities
2006 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan
2003
Trends in the search for bioactive microbial metabolites
1992 StandoutNobel
Bacteriuria in Women with Long-Term Catheters: Paired Comparison of Indwelling and Replacement Catheters
1988
Pathogenic Escherichia coli
2004 Standout
CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy ofHelicobacter pyloriinfection
2009
Neutrophils: Molecules, Functions and Pathophysiological Aspects
2000
Unique mechanism of for colonizing the gastric mucus
2000
A 5‐decade analysis of 13,715 carcinoid tumors
2003 Standout
BACTERIAL VIRULENCE IN URINARY TRACT INFECTION
1997
Role of the gut microbiota in nutrition and health
2018 Standout
Management of Patients With Ulcer Bleeding
2012 Standout
Serotypes, Hemagglutinins, Siderophore Synthesis, and Serum Resistance of Klebsiella Isolates Causing Human Urinary Tract Infections
1993
Antibacterial Natural Products in Medicinal Chemistry—Exodus or Revival?
2006
H pylori antibiotic resistance: prevalence, importance, and advances in testing
2004 Standout
Helicobacter pyloriInfection
2002 Standout
Treatment of Helicobacter pylori Infection: A Review of the World Literature
1996
C-glycosyl compounds bind to receptors on the surface of Escherichia coli and can target proteins to the organism
1992 StandoutNobel
Mannose‐sensitive haemagglutination in the absence of piliation in Escherichia coli
1990
Comparative Treatment of Helicobacter pylori–Positive Duodenal Ulcer Using Pantoprazole at Low and High Doses Versus Omeprazole in Triple Therapy
1999
Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole
2004
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
2015 Standout
Mechanism of pathogen‐specific TLR4 activation in the mucosa: Fimbriae, recognition receptors and adaptor protein selection
2005 StandoutNobel
Structure of the decoy module of human glycoprotein 2 and uromodulin and its interaction with bacterial adhesin FimH
2022 StandoutNobel
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Urease inhibitors as potential drugs for gastric and urinary tract infections: a patent review
2011
Infections Caused by Pseudomonas maltophilia with Emphasis on Bacteremia: Case Reports and a Review of the Literature
1982
Naturally Occurring Monobactams
1986
Basis for the selective antibacterial activity in vitro of proton pump inhibitors against Helicobacter spp
1997
Enterobacterial fimbriae
1987
Updated Functional Classification of β-Lactamases
2009 Standout
Helicobacter pylori Urease Suppresses Bactericidal Activity of Peroxynitrite via Carbon Dioxide Production
2000
Carbapenemases: the Versatile β-Lactamases
2007 Standout
Effect of gastric acid suppression on 13C‐urea breath test: comparison of ranitidine with omeprazole
2000
Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults
2005 Standout
AmpC β-Lactamases
2009 Standout
Correlation between in vitro and in vivo activity of antimicrobial agents against gram-negative bacilli in a murine infection model
1991
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Extended-Spectrum β-Lactamases: a Clinical Update
2005 Standout
Introduction to the human gut microbiota
2017 Standout
Common themes in microbial pathogenicity revisited
1997 Standout
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Relationship of type 1 pilus expression in Escherichia coli to ascending urinary tract infections in mice
1987
Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America
2010 Standout
Klebsiellaspp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors
1998 Standout
Three Decades of β-Lactamase Inhibitors
2010 Standout
Virulence factors in Escherichia coli urinary tract infection
1991
Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance
2001 Standout
Single Live Cell Imaging of Chromosomes in Chloramphenicol-Induced Filamentous Pseudomonas aeruginosa
2003
Organization and expression of genes responsible for type 1 piliation in Escherichia coli
1984
Expression of type 1 fimbriae may be required for persistence of Escherichia coli in the catheterized urinary tract
1987
The Placenta Harbors a Unique Microbiome
2014 Standout
Population shift in mannose-specific fimbriated phase of Klebsiella pneumoniae during experimental urinary tract infection in mice
1985
Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa
1995
In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections.
1996
Effect of temperature on antimicrobial susceptibilities of Pseudomonas maltophilia.
1985
Helicobacter pylori Adhesin Binding Fucosylated Histo-Blood Group Antigens Revealed by Retagging
1998 StandoutScience
A functional classification scheme for beta-lactamases and its correlation with molecular structure
1995 Standout
Molecular Biology and Pathogenicity of Mycoplasmas
1998 Standout
Induction and Evasion of Host Defenses by Type 1-Piliated Uropathogenic Escherichia coli
1998 StandoutScience
Growth inhibition of Ureaplasma urealyticum by the proton pump inhibitor lansoprazole: direct attribution to inhibition by lansoprazole of urease activity and urea-induced ATP synthesis in U. urealyticum
1995
Functional Significance of Cell Volume Regulatory Mechanisms
1998 Standout
Decreased expression of mannose-specific adhesins by Escherichia coli in the colonic microflora of immunoglobulin A-deficient individuals
1996
Review article: current perspectives on hypergastrinaemia and enterochromaffin‐like‐cell hyperplasia
1999
Interaction of a Pyelonephritogenic Escherichia Coli Strain with the Tissue Components of the Mouse Urinary Tract
1986
Treatment options for Helicobacter pylori infection when proton pump inhibitor‐based triple therapy fails in clinical practice
1999
Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia
1998 Standout
Lung Infections Associated with Cystic Fibrosis
2002 Standout
Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat
2001 Standout
Prevention of urinary tract infection in rats with an indigenous Lactobacillus casei strain
1985
Works of T Iwahi being referenced
Antibacterial properties of SCE-2787, a new cephem antibiotic
1992
TAN-1057 A-D, new antibiotics with potent antibacterial activity against methicillin-resistant Staphylococcus aureus. Taxonomy, fermentation and biological activity.
1993
Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori
1991
Role of type 1 fimbriae in the pathogenesis of ascending urinary tract infection induced by escherichia coli in mice
1983
Interaction of Escherichia coli with polymorphonuclear leukocytes in pathogenesis of urinary tract infection in mice
1988
Cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities
1981
Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells
1993
Virulence of Escherichia Coli in Ascending Urinary-tract Infection in Mice
1982
In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum
1992